Per DJT. That’ll show those elitist diabetes/weight-loss drug consumers! Some back of envelope calculations for Wegovy and Ozempic (both manufactured by Novo Nordisk).
Current list price, implied given US is small country (as in behavior of steel tariffs):
$1,349.02 per package (Wegovy) 28 days ==> $2698.04
$936 30 day supply (Ozempic) ==> $1872.60
Competing product, from Eli Lilly:
$1086.37 per fill (30 days) (Zepbound) ==> above $1872.60 (assuming substitutable for Ozempic)
If one has to google the word “tariff” to find out what it means, you might be surprised to find out the domestically produced alternative has a price increase. But that’s the point of tariffs — to increase producer surplus for domestic producers (see block a in the graphs in this post).
Addendum, 4:21pm PT:
Why stop at 100%. Why not 1000%. The bigger it is, the bigger the increase in consumer surplus, right?